VANCOUVER, B.C., Feb. 12, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced the appointment of Ms. Peggy Phillips to its Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
